Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
08:30am, Monday, 04'th Mar 2024
SAN FRANCISCO , March 4, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company developing medicines for the treatment of auto-immune disorders, today announced that it has e
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
06:00pm, Tuesday, 27'th Feb 2024
SAN FRANCISCO , Feb. 27, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at the upcoming TD Cowen 44th Annual Health Care Conference in Boston on Tuesday, Ma
SAN FRANCISCO , Feb. 26, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2023 on Monday, March 4, 2024, a
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
11:06am, Tuesday, 20'th Feb 2024
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
06:00pm, Wednesday, 03'rd Jan 2024
SAN FRANCISCO , Jan. 3, 2024 /PRNewswire/ -- Nektar (Nasdaq: NKTR) management is scheduled to present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Janua
– NKTR-255 Combination Expanded NK Cells and Enhanced ADCC Against Rituximab-Resistant Burkitt Lymphoma (BL) Cells – SAN FRANCISCO , Dec. 11, 2023 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKT
Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue?
12:47pm, Thursday, 07'th Dec 2023
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock?
Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss
01:31pm, Wednesday, 08'th Nov 2023
Nektar (NKTR) misses third-quarter estimates for the bottom line but beats the same for the top line.
Nektar Therapeutics (NKTR) Q3 2023 Earnings Call Transcript
09:11pm, Tuesday, 07'th Nov 2023
Nektar Therapeutics (NASDAQ:NKTR ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, IR and Corporate Affairs Howard Robin - President and CEO Jon
SAN FRANCISCO , Oct. 31, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2023 on Tuesday, November 7, 2023, after the close of U.S.-ba
Nektar (NKTR), Cellular Biomedicine Join for Lung Cancer Studies
09:01am, Thursday, 28'th Sep 2023
Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC.
Nektar (NKTR) Up on Positive New Data From Eczema Study
09:01am, Thursday, 14'th Sep 2023
Nektar (NKTR) gains on positive new data for its pipeline candidate, rezpegaldesleukin, evaluated from an early-stage study for treating atopic dermatitis.
Best Penny Stocks To Buy Now? 10 Under $1 To Watch
01:05pm, Wednesday, 13'th Sep 2023
Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane returns.
Best Penny Stocks To Buy Now? 7 Under $1 To Watch
02:22pm, Monday, 11'th Sep 2023
Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently high-risk investments, the potential reward with th
5 Top-Ranked Stocks With Rising P/E for Solid Returns
09:46am, Thursday, 24'th Aug 2023
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Nektar Therapeutics (NKTR), Energous (WATT), DocuSign (DOCU), OptiNose (OPTN) and Canadian Solar (CSIQ)
